Wu Qingjun Dako for the background is as follows:
Dako for the earliest is by Wu Qingjun, He Junfeng, respectively, 300,000 yuan, 200,000 yuan in 1999, the establishment of limited company. 2016, Dako for the overall change into a limited liability company, that is, at this time, Wu Yingjie (Wu Qingjun's daughter), He Zhenglong appeared in the shareholder name list.
Dako for said that He Zhenglong has the qualifications to become a shareholder of the company, and his shareholder rights can be exercised by his legal agent, He Junfeng, on his behalf.
Zhejiang letter specializing in law firm lawyer LouXiaoYun further explained that, although this situation in practice is not common, but the company law on minors can become shareholders of the company did not make restrictive provisions. Therefore, the minor can become a shareholder, its shareholder rights can be exercised by the legal representative.
The prospectus shows that Dako is a specialized provider focusing on life science research services and pathology diagnosis.
In the field of life science research services, Dako is mainly engaged in the agent sales of scientific research reagents and instruments, as well as some of the scientific research reagents of independent research and development, production and sales.
In the field of pathology diagnostics, Daktronics is mainly engaged in the research, development, production and sales of pathology diagnostic equipment and reagents.
Beijing Dako Bio-Technology Co., Ltd.
Beijing Dako Bio-Technology Co., Ltd. was founded on January 30, 2008, with its registered office located in Room 601-606, 6th Floor, Building 5, No. 38, Linfeng Second Road, Haidian District, Beijing, and its legal representative is Wu Qingjun.
The scope of business includes general items: technical services, technology development, technology consulting, technology exchange, technology transfer, technology promotion; import and export of goods; import and export of technology; import and export agency; the first class of medical devices sales; the second class of medical devices sales; instrumentation sales; chemical products sales (excluding licensed chemical products).
Medical research and experimental development; non-residential real estate leasing. (In addition to projects subject to approval by law, with a business license to carry out business activities independently according to law.)Licensed projects: the second category of value-added telecommunications services; Internet information services.
Third class medical device business. (Projects subject to approval by law, approved by the relevant departments before carrying out business activities, the specific business projects to the relevant departments to approve the documents or licenses shall prevail) (shall not be engaged in national and municipal industrial policy prohibitions and restrictions on the type of project business activities.) Beijing Dako for Biotechnology Co., Ltd. has invested in 3 companies externally and has 8 branches.